MS Research Updates

MS Queensland works closely and collaboratively with our national research arm, MS Research Australia, and provides funding towards MS Research Australia’s research effort. MS Research Australia implements an informed scientific agenda to accelerate advances that will prevent, better treat and ultimately cure multiple sclerosis.

As a part of the research effort, MS Research Australia provides updates on some of the major breakthroughs in MS Research.

Non-Invasive Method Promotes Survival of Myelin-Producing Cells

17 July, 2019

  • An Australian team has looked at a non-invasive method for promoting myelin production in the brain as a way to boost natural myelin repair.
  • In exciting new results, they have found that this method promotes the survival and maturation of myelin-producing cells in the brain.

Read the full article

Anti-EBV Trial Shows Promise in Progressive MS

20 November, 2018
  • A treatment called ‘adoptive T cell immunotherapy’ – which targets the Epstein Barr virus (EBV) – was shown to be safe in a group of 10 patients with primary and secondary MS in a small phase I (safety) trial
  • Larger studies are now underway to test the safety and effectiveness of the treatment

Read the full article




Blocking Blood Protein Could Protect Nerves in MS

08 November, 2018
  • Fibrin is a protein that accumulates in the brain in diseases such as MS and Alzheimer’s disease and may play a role in tissue damage, but due to its essential role in blood clotting, successful treatments that can safely block fibrin in the brain have remained elusive.
  • While still in the early stages, if this research can be validated in humans, it may represent the first step in developing a new type of treatment for damage seen in MS and other diseases.

Read the full article


The Shifting Goalposts for MS Treatment

30 October, 2018
  • The changing medication landscape means that neurologists now have more possibilities to optimise MS treatments for individual circumstances.
  • Doctors are tolerating less and less disease activity and do switch medications even after one silent MRI brain lesion, highlighting the importance of regular scans.

Read the full article